We identified MiR181ab1 as a miRNA cluster upregulated by oncogenic KRAS and used multiple genetically engineered mouse models (GEMMs) to demonstrate a role for this cluster in both initiation and maintenance of lung and pancreatic cancer. This evidence concerns the gene KRAS and pancreatic neoplasm.